Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SNY - Sanofi Regeneron win Japan approval for Dupixent in CSU indication

SNY - Sanofi Regeneron win Japan approval for Dupixent in CSU indication

Sanofi

2024-02-16 06:17:43 ET

Sanofi ( NASDAQ: SNY ) and Regeneron Pharmaceuticals ( NASDAQ: REGN ) announced Friday marketing and manufacturing authorization for their blockbuster anti-inflammatory medication, Dupixent, in Japan for the treatment of chronic spontaneous urticaria (CSU) – a chronic inflammatory skin disease....

For further details see:

Sanofi, Regeneron win Japan approval for Dupixent in CSU indication
Stock Information
Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com
Menu
SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...